Medpace Holdings Total Liabilities 2014-2023 | MEDP

Medpace Holdings total liabilities from 2014 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Medpace Holdings total liabilities for the quarter ending December 31, 2023 were $1.098B, a 13.64% increase year-over-year.
  • Medpace Holdings total liabilities for 2023 were $1.098B, a 13.64% increase from 2022.
  • Medpace Holdings total liabilities for 2022 were $0.966B, a 36.65% increase from 2021.
  • Medpace Holdings total liabilities for 2021 were $0.707B, a 20.88% increase from 2020.
Medpace Holdings Annual Total Liabilities
(Millions of US $)
2023 $1,098
2022 $966
2021 $707
2020 $585
2019 $417
2018 $378
2017 $447
2016 $368
2015 $571
2014 $695
2013 $0
Medpace Holdings Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $1,098
2023-09-30 $1,016
2023-06-30 $1,016
2023-03-31 $1,048
2022-12-31 $966
2022-09-30 $979
2022-06-30 $1,032
2022-03-31 $739
2021-12-31 $707
2021-09-30 $679
2021-06-30 $618
2021-03-31 $592
2020-12-31 $585
2020-09-30 $505
2020-06-30 $484
2020-03-31 $420
2019-12-31 $417
2019-09-30 $380
2019-06-30 $359
2019-03-31 $385
2018-12-31 $378
2018-09-30 $388
2018-06-30 $428
2018-03-31 $462
2017-12-31 $447
2017-09-30 $399
2017-06-30 $356
2017-03-31 $345
2016-12-31 $368
2016-09-30 $366
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2014-12-31 $695
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $12.117B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $122.161B 15.33
Cencora (COR) United States $44.832B 17.48
DiDi Global (DIDIY) China $24.983B 0.00
ICON (ICLR) Ireland $24.837B 23.45
Avantor (AVTR) United States $16.520B 24.32
Viatris (VTRS) United States $13.812B 3.97
CochLear (CHEOY) Australia $13.622B 0.00
Revvity (RVTY) United States $12.486B 21.88
Charles River Laboratories (CRL) United States $11.842B 21.59
EUROFINS SCIENT (ERFSF) Luxembourg $11.592B 0.00
Natera (NTRA) United States $11.317B 0.00
Solventum (SOLV) United States $11.238B 0.00
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
HealthEquity (HQY) United States $6.843B 51.12
Organon (OGN) United States $5.015B 4.76
Bausch + Lomb (BLCO) Canada $4.870B 19.52
Doximity (DOCS) United States $4.537B 33.78
PACS (PACS) United States $3.752B 0.00
Surgery Partners (SGRY) United States $3.178B 29.41
Sotera Health (SHC) United States $3.088B 15.15
Progyny (PGNY) United States $3.082B 51.73
Life Times (LTH) United States $2.779B 29.44
GoodRx Holdings (GDRX) United States $2.769B 140.20
Premier (PINC) United States $2.543B 9.31
AMN Healthcare Services Inc (AMN) United States $2.281B 7.38
Teladoc Health (TDOC) United States $2.203B 0.00
Agilon Health (AGL) United States $1.985B 0.00
BrightSpring Health Services (BTSG) United States $1.893B 0.00
NovoCure (NVCR) Jersey $1.527B 0.00
Agiliti (AGTI) United States $1.369B 22.36
Establishment Labs Holdings (ESTA) $1.359B 0.00
Alignment Healthcare (ALHC) United States $1.003B 0.00
Pediatrix Medical (MD) United States $0.766B 7.93
Embecta (EMBC) United States $0.589B 3.89
InnovAge Holding (INNV) United States $0.554B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.511B 0.00
LifeMD (LFMD) United States $0.511B 0.00
GeneDx Holdings (WGS) United States $0.508B 0.00
Enhabit (EHAB) United States $0.501B 45.41
Auna S.A (AUNA) Luxembourg $0.500B 0.00
CareDx (CDNA) United States $0.480B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
MultiPlan (MPLN) United States $0.429B 0.00
Beauty Health (SKIN) United States $0.399B 0.00
DocGo (DCGO) United States $0.366B 58.50
Sera Prognostics (SERA) United States $0.345B 0.00
ModivCare (MODV) United States $0.312B 5.85
Sharecare (SHCR) United States $0.269B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.150B 0.00
So-Young (SY) China $0.128B 43.00
Oncology Institute (TOI) United States $0.086B 0.00
Pono Capital Two (PTWO) United States $0.072B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
NeueHealth (NEUE) United States $0.050B 0.00
Co-Diagnostics (CODX) United States $0.038B 0.00
SeaStar Medical Holding (ICU) United States $0.037B 0.00
Nutex Health (NUTX) United States $0.032B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Singular Genomics Systems (OMIC) United States $0.030B 0.00
OncoCyte (OCX) United States $0.023B 0.00
DermTech (DMTK) United States $0.022B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.014B 0.00
BIMI Holdings (BIMI) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
OpGen (OPGN) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.005B 0.00
Assure Holdings (IONM) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00